Maurice Tutor

(5)

$15/per page/Negotiable

About Maurice Tutor

Levels Tought:
Elementary,Middle School,High School,College,University,PHD

Expertise:
Algebra,Applied Sciences See all
Algebra,Applied Sciences,Biology,Calculus,Chemistry,Economics,English,Essay writing,Geography,Geology,Health & Medical,Physics,Science Hide all
Teaching Since: May 2017
Last Sign in: 398 Weeks Ago, 1 Day Ago
Questions Answered: 66690
Tutorials Posted: 66688

Education

  • MCS,PHD
    Argosy University/ Phoniex University/
    Nov-2005 - Oct-2011

Experience

  • Professor
    Phoniex University
    Oct-2001 - Nov-2016

Category > Management Posted 16 Feb 2018 My Price 8.00

commercialization of medicines

I1-45.      Computing Return on Equity and Return on Assets     (Lo4)

 

The following table contains financial statement information for astraZeneca, which is a global bio- pharmaceutical company focused on discovery, development, manufacturing and commercialization of medicines and is headquartered in london, uK.

 

 

 

($ millions)

total assets

net income

sales

equity

2010 . . . . . . . . . .

$56,127

$8,106

$33,269

$23,410

2011 . . . . . . . . . .

52,830

9,470

33,591

23,472

2012 . . . . . . . . . .

53,534

6,405

27,973

23,952

 

 

 

required

 

a.       Compute the return on equity (rOe) for 2011 and 2012. What trend, if any, is evident? how does AstraZeneca’s  rOe  compare  with  the  approximately  21.5%  median  rOe  for  companies  in  the Dow Jones industrial average for 2012?

 

b.       Compute the return on assets (rOA) for 2011 and 2012. What trends, if any, are evident? how does AstraZeneca’s rOA compare with the approximate 6.7% median rOA for companies in the Dow Jones industrial average for 2012?

 

c.       What factors might allow a company like AstraZeneca to reap above-average returns?

 

 


Answers

Maurice Tutor
(5)
Status NEW Posted 16 Feb 2018 09:02 PM My Price 8.00

Hel-----------lo -----------Sir-----------/Ma-----------dam-----------Tha-----------nk -----------You----------- fo-----------r u-----------sin-----------g o-----------ur -----------web-----------sit-----------e a-----------nd -----------acq-----------uis-----------iti-----------on -----------of -----------my -----------pos-----------ted----------- so-----------lut-----------ion-----------.Pl-----------eas-----------e p-----------ing----------- me----------- on-----------cha-----------t I----------- am----------- on-----------lin-----------e o-----------r i-----------nbo-----------x m-----------e a----------- me-----------ssa-----------ge -----------I w-----------ill----------- be-----------

Not Rated(0)